We don’t have many of these, because viruses evolve too fast, infections are diagnosed too slow, & unlike bacteria, viruses can be so different that there aren’t many broad spectrum antibiotics. The AViDD centers were funded to develop antivirals for potential pandemic viruses.
Like the ASAP center based at Sloan Kettering, which was using AI structural analysis to predict & test molecules targeting 3 virus families: coronaviruses, flaviviruses (dengue, yellow fever, Zika, West Nile, HCV), & picornaviruses (polio, EV-D68, FMDV).
Or the AC/DC center at Emory, developing nucleoside analogs & polymerase inhibitors against CoVs, flavis, picornas, paramyxoviruses (Nipah, Hendra, measles, RSV), & togaviruses (Chikungunya, VEEV/WEEV/EEEV). They had 4 drugs to test & were screening more.
At Scripps there was CAMPP, focused on CoVs, flavis, & hemorrhagic fever viruses (filoviruses: Ebola, Marburg; bunyaviruses: SFTSV; arenaviruses: Lassa). They were advancing promising oral candidates as well as finding drugs with new mechanisms of action.
I was fortunate enough to be invited to speak at a pandemic preparedness seminar hosted by CAMPP last month, where I got to hear from a number of colleagues doing amazing antiviral discovery work in CAMPP & other AViDD centers. And all anyone could talk about was H5N1.
In fact, I was on my way to the symposium getting calls from reporters about another hospitalized H5N1 patient as well as new pre immune studies just out. Flu antivirals don’t work very well & can develop resistance quickly, so new antivirals are crucial for flu pandemics.
In my talk, I went over how slashing & burning government personnel, data, & funding will devastate our ability to prevent & respond to an H5N1 pandemic. Now CAMPP & the AViDD program can be added to my slide on the destruction of American readiness.
Also lost is this AViDD center at Stanford focused on multiple drugs targeting all RNA viruses via a combo of mechanisms: small molecule inhibitors, antisense, & protein drugs. Combination therapies are much less likely to select for resistance mutations.
The MAVDA center sought novel drug targets in CoVs, flaviviruses, & alphaviruses like CHIKV. Charlie Rice won the Nobel prize in 2021 for work that led to drugs that cured HCV. I’ve known him since I was a postdoc. He’s brilliant & also a very kind person
The Midwest AViDD Center at U of Minnesota was doing a lot of sophisticated high throughput screening to find novel antivirals for SARS2 and also hemorrhagic arenaviruses, filoviruses, & flaviviruses. Also a training/outreach component for effective use.
This center at UCSF is led by world class viral proteomics experts (also shout to Regina, SK, where Nevan is from, so I’ll forgive him for being a Niners fan). They were developing novel targeted drugs for 8 viral families! All gone now.
This goes out to all the lab leakers who have baselessly accused Ralph Baric of making SARS-CoV-2. No. His READDI AViDD Center was making new drugs to treat emerging CoVs & other viruses. He was trying to prevent or end pandemics, not start them.
Finally this AViDD center at UTMB was targeting proteases and polymerases to develop new drugs against coronaviruses, flaviviruses, & henipaviruses (Hendra & Nipah). All emerging viruses we need better drugs for.
These AViDD centers were an investment in our future, developing medicines that we could use to prevent or respond to viral pandemic threats. They employed hundreds of people & contributed to the economy as well as our toolbox of countermeasures.
And that’s no longer a priority.
How can the government claim it is making America healthy again when it’s literally shutting down research that would keep Americans healthy from pandemic viral pathogens? We need more ways to treat viral diseases, not less. We need more antiviral drugs.
And how does it benefit the American taxpayer to put hundreds of Americans out of work? I’m not an economist but I’m pretty sure that swelling the ranks of the unemployed is not a good way to boost the economy.
Cutting programs like AViDD makes us less prosperous, less innovative, less competent, less prepared, and less safe. We will have fewer countermeasures to fight emerging viruses. We are falling behind.
This is not just a funding cut. It’s an attack on our well-being.
We aren’t helpless here. Congress must step in and insist that appropriations are applied as they have decided. DOGE & Trump do not legally have the right to can programs that Congress paid for. So call your representatives & demand they step up.
AViDD invested our tax dollars in the future health of the American people. I reject a regime that attacks science, puts Americans out of work, & endangers us all on the whims of idiot billionaires with authoritarian ambitions. We should demand the return on our investment.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
I am often challenged to provide an example of a vaccine that could not have been developed without doing gain-of-function virology research.
Thanks to HHS @SecKennedy and former @BiosafetyNow board member @DrJBhattacharya, I now have an answer:
Generation Gold Standard
Can't complain about half a billion for a "next-generation universal vaccine platform"! What is this amazingly innovative new vaccine technology? Tell me more, because this says "BPL-inactivated, whole virus platform". That describes current flu vaccines. hhs.gov/press-room/hhs…
The press release did not offer more details so I looked at a paper about it. This was testing a quadrivalent BPL-inactivated vaccine (vaccine made of 4 inactivated low path avian viruses) by a heterosubtypic (different HxNy subtype) challenge. pmc.ncbi.nlm.nih.gov/articles/PMC11…
I am the co-Editor-in-Chief of @Els_Vaccine & I’ll be the first to say that a lot about academic publishing needs reform.
But replacing peer review with ideologically-driven censorship or shutting journals down in the name of “free speech” is not reform.
FYI to the NIH Director: having your paper rejected because peer reviewers found it lacked scientific merit is not censorship or gatekeeping. It means your work didn’t pass muster & wasn’t up to scientific standards. Expert peer review is what distinguishes a journal from a blog.
I can’t speak for CHEST but I assume their editorial viewpoint is similar to @Els_Vaccine’s: publish the best quality scientific work in the field (vaccines in Vaccine, chests in CHEST). If your paper is rejected, it’s because it wasn’t of sufficient quality or rigor, not POV.
The clade 2.3.4.4.b viruses circulating in the US have infected many different mammalian species. In the course of this, we are seeing many opportunities for these viruses to adapt to mammalian hosts, including switching receptor usage & increasing virus fitness.
Viruses going back & forth in many mammalian hosts creates a lot of unique and complex selection pressures. It also leads to more infected individual animals, including in species we have frequent contact with: cows, poultry, dogs, cats, rodents, peridomestic wildlife.
Take the National Flu Surveillance numbers. When President Trump was sworn in on Jan 20, 89K specimens were tested using an assay that can detect novel flu A viruses. To date this has identified 3 H5N1 cases.
Hardly a surprise that Tracy Beth Høeg is now in at FDA as the Grima Wormtongue to Commissioner Marty Makary.
Høeg’s only “extensive experience working in vaccine science” is making up imaginary risks about vaccination to further monetize her various anti-vax platforms.
Like her fellow contrarians in the HHS conman clown car, she’s been persecuted & censored by the public health industrial complex for her dissenting views.
Evidently LinkedIn removing false info—like this omg plasmids with a SV40 origin in Pfizer vaccines thing—is proof of truth
But it isn’t censorship to point out when someone is wrong—especially if it’s intentional. That’s also called lying & Høeg has been doing it about infectious diseases & vaccines for years now.
I’ve now been asked about the USDA H5N1 action plan quite a few times, so maybe I should say a few things about it.
There are a few things I like about it, more things I don’t, and some things about it that are completely WTAF.
This is the 5 step plan:
Basically this is the plan:
$500M for biosecurity improvements
$400M for indemnifying producer losses
Deregulation
$100M for vaccine research
Relax import controls to make it easier to buy flu-free eggs from abroad
Obv I think investing $100M in vaccine research is a great idea. IMO the cow & poultry outbreaks will not be controlled without vaccination. It’s backed up by evidence from 🇨🇳 & 🇲🇽 that it ends avian outbreaks & stops transmission to humans.